Bio-Rad Labs (BIO) Tops Q3 EPS by 85c, Beats on Revenue
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $280.92 +3.92%
EPS Growth %: -30.7%
Financial Fact:
Cost of goods sold: 236.55M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -30.7%
Financial Fact:
Cost of goods sold: 236.55M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $2.01, $0.85 better than the analyst estimate of $1.16. Revenue for the quarter came in at $649.7 million versus the consensus estimate of $628.18 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras CEO says investors misunderstood margin guidance
- TotalEnergies joins Bab Gas Cap concession in Abu Dhabi with 10% stake
- AdaptHealth Corp. (AHCO) 6K contracts of September 10 calls active
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
